<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Early and delayed single <z:chebi fb="23" ids="30212">photon</z:chebi> emission computed tomography (SPECT) using N-<z:chebi fb="0" ids="30353">isopropyl</z:chebi>-p-(123I)iodoamphetamine (<z:chebi fb="54" ids="17202">IMP</z:chebi>) was performed on 28 subjects (2 <z:mpath ids='MPATH_458'>normal</z:mpath>, 12 with cerebrovascular diseases and 14 with <z:mp ids='MP_0009277'>brain tumors</z:mp>) to evaluate the reversibility of the cerebral abnormality and cerebral viability </plain></SENT>
<SENT sid="1" pm="."><plain>The results were compared with X-ray CT, 99mTc brain scintigraphy and rCBF by 133Xe inhalation method </plain></SENT>
<SENT sid="2" pm="."><plain>Three types of <z:chebi fb="54" ids="17202">IMP</z:chebi> kinetics were observed </plain></SENT>
<SENT sid="3" pm="."><plain>Initial <z:mp ids='MP_0001402'>hypoactivity</z:mp> that changed over 4 to 6 hours approaching a <z:mpath ids='MPATH_458'>normal</z:mpath> pattern suggests a hypofunctional parenchyma without significant tissue damage: long-lasting abnormalities on <z:chebi fb="54" ids="17202">IMP</z:chebi> SPECT indicates cellular damage </plain></SENT>
</text></document>